If it’s absolutely legal and ethical and in the state’s best interest for the Crime Lab to contract with a company owned by its assistant director, and if no bidding is necessary on the specific item being purchased, why pay extra for a middleman? read more >
Some University of Arkansas for Medical Sciences employees saw red flags long before auditors discovered a deficit at the Myeloma Institute for Research & Therapy that was allowed to grow to $29 million over nine years. read more >
Dr. Gareth Morgan, former director of the Myeloma Institute for Research & Therapy at the University of Arkansas for Medical Sciences in Little Rock, said $29 million in operating losses detected by a recent audit were “accounting errors” outside his control. read more >
When the University of Arkansas for Medical Sciences announced in April 2014 that Dr. Gareth Morgan would lead the Myeloma Institute for Research & Therapy, it was cause for a celebration.
The cheers didn’t last long. read more >
Tiffani Foltz has been named a director of development for the University of Arkansas for Medical Sciences in Little Rock, where she will focus on fundraising activities for the Myeloma Institute. read more >
Dr. Bart Barlogie said that at the myeloma program at Mount Sinai he’ll be doing clinical care and research and “dedicating myself to finding answers to high-risk myeloma,” just as he did at UAMS. read more >
The University of Arkansas for Medical Sciences has named Dr. Bart Barlogie as a distinguished professor of medicine and pathology in the College of Medicine in a resolution from the University of Arkansas System Board of Trustees. read more >